Pros Holdings Inc (PRO) Stock News

Profound Medical (PROF) surged 21.7% following strong preliminary Q3 2026 revenue guidance of $9.8-10 million, representing 85-89% year-over-year growth and 45-47% above analyst consensus. The company expects gross margins exceeding 70%, signaling improved commercial momentum. However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock's momentum may not sustain without further positive estimate revisions.

The Canine Project, a dog beauty and skincare brand, announced the October 15 launch of FURVIVE™ Restorative Shampoo + Conditioner + Body Wash. The all-in-one product combines Brazilian Copaiba botanical with premium skincare ingredients like Niacinamide, Hyaluronic Acid, and Argan Oil, formulated specifically for canine skin. Priced at $33 for 12 fl oz, it will be available on the company's website and Amazon.

Dimensional Fund Advisors Ltd. has disclosed a public opening position in Prologis Inc, holding 12,123,997 USD 0.01 common shares representing 1.28% of the company as of October 7, 2026. The disclosure was made under Rule 8.3 of the Takeover Code, with the fund also making disclosures regarding Segro PLC. A purchase of 1,501 shares at $127.84 per unit and a transfer in of 8,787 shares were noted in the dealing section.

Dimensional Fund Advisors Ltd. has disclosed a 1.28% interest in Prologis Inc., comprising 12,115,060 USD 0.01 common shares as of October 6, 2026. The disclosure includes recent dealings with purchases of 1,011 shares at $128.05 and sales of 9,951 shares at $128.68, along with a transfer in of 678 shares. Dimensional also disclosed interests in Segro PLC in relation to the same offer.

Dimensional Fund Advisors Ltd. has disclosed a 1.28% interest in Prologis Inc, comprising 12,095,632 USD 0.01 common shares as of September 30, 2026. The disclosure includes recent purchases of 3,374 shares at $131.47 and 901 shares at $29.84, along with a transfer in of 4,928 shares. The filing also indicates concurrent disclosures regarding Segro PLC.

A lawsuit was filed on July 24, 2026, against PROCEPT BioRobotics Corporation alleging the company misrepresented U.S. handpiece unit sales through an undisclosed discount program that incentivized bulk orders beyond actual demand, artificially inflating reported sales and exposing the company to material operational and financial risks.

Trio Petroleum Corp acquired 24 oil wells (4 producing, 20 shut-in) from Marlin Resources Ltd in Saskatchewan's Lloydminster region for CDN$800,000 cash plus an underutilized water disposal asset. The acquisition includes 37 BOPD of current production, a planned Cummings multilateral well with CDN$1.2 million development budget, and a CDN$425,000 workover program. The company expects the purchase price per flowing barrel to be discounted compared to market rates for comparable assets.

Faruqi & Faruqi, LLP is investigating potential securities fraud claims against Wise Group plc (NASDAQ: WSE), alleging the company made false and misleading statements about its anti-money laundering and counter-terrorism financing compliance efforts ahead of its NASDAQ debut. Investors who purchased Wise securities between May 11, 2026 and July 23, 2026 have until September 29, 2026 to seek lead plaintiff status in the federal class action lawsuit.

A securities class action lawsuit has been filed against Pentair plc alleging the company made false statements about its business prospects while failing to disclose significant inventory destocking in its Pool channel. The undisclosed destocking negatively impacted Pool segment sales by approximately $170 million and income by $105 million in Q2 2026, causing the stock to fall 15% on July 15, 2026. Investors who purchased Pentair securities between March 11, 2025 and July 14, 2026 have until October 2, 2026 to seek lead plaintiff status.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Capricor Therapeutics for allegedly making misleading statements about its Deramiocel drug's regulatory prospects. The company allegedly failed to disclose changes to its statistical analysis plan and lack of FDA agreement before resubmitting the Biologics License Application. Capricor's stock plummeted 64% on July 27, 2026, after the FDA released unfavorable briefing documents, and fell an additional 36% on July 30, 2026, following an AdCom panel's 9-3 vote against the drug's efficacy. Investors who purchased securities between December 17, 2025 and July 26, 2026 may be eligible to participate in the class action lawsuit, with a September 28, 2026 deadline to seek lead plaintiff status.

A securities class action lawsuit has been filed against Rackspace Technology for allegedly misleading investors about the financial impact of its AI strategy, declining Public Cloud revenue, and reduced infrastructure resale business. The company reduced its full year 2026 revenue guidance by $150 million on July 9, 2026, causing its stock to fall 33.6%. The deadline to seek lead plaintiff status is September 28, 2026.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Bloom Energy Corporation, alleging the company made false statements about its supply chain by understating reliance on Chinese scandium sourced through intermediaries. Following a July 8, 2026 report by Hunterbrook Media exposing the company's China-linked supply routes, Bloom Energy's stock fell 5.7%. Investors who purchased securities between February 27, 2025 and July 8, 2026 have until September 28, 2026 to seek lead plaintiff status in the class action lawsuit.

A securities class action lawsuit has been filed against Blaize Holdings, Inc. (NASDAQ: BZAI) alleging that the company made false and misleading statements about revenue recognition and announced transactions with unequipped entities to artificially boost growth. The allegations were highlighted by a Pelican Way Research report on April 28, 2026, which claimed Blaize engaged in a bogus deal with a 4-month-old counterparty, causing the stock to fall 12.03% that day. Investors who purchased Blaize securities between July 18, 2025 and April 28, 2026 have until October 5, 2026 to seek lead plaintiff status.

Grabar Law Office announced investigations into potential breaches of fiduciary duties by officers and directors at Doximity, GoDaddy, Planet Fitness, and PROCEPT BioRobotics. The investigations follow federal securities class action filings alleging misleading statements regarding business metrics, pricing strategies, and financial guidance. Long-term shareholders meeting specific holding periods are eligible to seek corporate reforms and potential compensation at no cost.

Amplify ETFs announced the filing of PROS, a first-of-its-kind actively managed ETF designed to provide investors access to professional sports team ownership through a combination of public and private investments. The fund will invest at least 80% of assets in equity securities tied to major professional sports leagues and organizations, with up to 15% in private investments.

A class action lawsuit has been filed against PROCEPT BioRobotics Corporation for allegedly making materially false statements about its business between February 2024 and February 2026. The company allegedly used an undisclosed discount program to artificially inflate handpiece sales, leading to excess inventory of over 10,000 units. Stock price declined significantly following three earnings announcements revealing lower-than-expected sales and inventory issues. Shareholders have until September 22, 2026 to file lead plaintiff motions.

Kaplan Fox has filed a class action lawsuit against PROCEPT BioRobotics Corporation for allegedly misleading investors about the relationship between handpiece unit sales and procedures. The complaint alleges that undisclosed discount programs artificially inflated reported U.S. handpiece unit sales and revenues by pulling forward demand. Investors who purchased PROCEPT common stock between February 28, 2024 and February 25, 2026 may be eligible to participate in the class action, with a deadline of September 22, 2026 to seek a lead plaintiff role.

A securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation for allegedly misleading investors about handpiece sales through undisclosed bulk discount programs that artificially inflated revenues. The company pulled forward sales from future quarters to meet expectations, resulting in excess customer inventory of over 10,000 units. PROCEPT shares declined over 48% from August 2025 to February 2026 as the truth emerged through a series of earnings misses and subsequent disclosures.

A securities class action lawsuit has been filed against PROCEPT BioRobotics Corporation for allegedly making materially false statements regarding handpiece unit sales and revenues. The lawsuit claims the company used undisclosed discount programs to artificially inflate sales figures, created excess inventory of over 10,000 units, and failed to disclose material risks. Investors who purchased stock between February 28, 2024 and February 25, 2026 may be eligible for compensation, with a September 22, 2026 deadline to serve as lead plaintiff.

A class action lawsuit has been filed against PROCEPT BioRobotics Corporation for allegedly making materially false statements regarding its handpiece unit sales and revenues. The company allegedly used an undisclosed extensive discount program to artificially inflate sales by pulling forward orders, creating over 10,000 excess units in field inventory and causing the company to miss its 2025 guidance. Investors who purchased stock between February 28, 2024 and February 25, 2026 can apply to be lead plaintiff by September 22, 2026.

Dimensional Fund Advisors Ltd. has disclosed a 1.27% interest in Prologis Inc., comprising 12,071,785 USD 0.01 common shares as of September 17, 2026. The disclosure was made under Rule 8.3 of the Takeover Code, with a purchase of 158 shares at $134.8566 per unit and a transfer out of 286 shares during the reporting period.

Schall, Brown & Schwartz LLP announced a class action securities fraud lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) for violations of the Securities Exchange Act. The lawsuit alleges the company made false and misleading statements by using large discounts to inflate current revenue, pulling orders forward, and materially overstating handpiece unit utilization. The class period spans February 28, 2024 to February 25, 2026, with a September 22, 2026 deadline for investors to participate.

A securities class action has been filed against PROCEPT BioRobotics for allegedly misleading investors about handpiece sales performance. The company allegedly used undisclosed bulk order discount programs to artificially inflate sales figures by pulling forward future quarter sales, resulting in excess customer inventory exceeding 10,000 units. The stock declined over 48% from August 2025 to February 2026 as the truth emerged through quarterly earnings misses and management disclosures.

PROCEPT BioRobotics faces a securities fraud class action lawsuit for failing to disclose material inventory issues. The company revealed that handpiece sales had materially exceeded procedures since Q1 2023, resulting in over 10,000 units of excess field inventory. This disclosure caused the stock to decline 18% in two days, from $27.84 to $22.69 per share, as quarterly handpiece sales dropped nearly 30% and the company missed annual revenue guidance by tens of millions of dollars. Investors have until September 22, 2026 to file lead plaintiff applications.

Rosen Law Firm announces a September 22, 2026 deadline for investors to join a securities class action against PROCEPT BioRobotics Corporation. The lawsuit alleges the company made materially false statements regarding its handpiece unit sales and revenues, claiming an undisclosed discount program artificially inflated sales figures, created excess inventory of over 10,000 units, and that the company could not achieve its 2025 guidance.

UMH Properties, Inc., a REIT specializing in manufactured home communities, announced it will host its Third Quarter 2026 Financial Results Webcast and Conference Call on November 3, 2026. The company will release Q3 2026 results on November 2, 2026, and discuss market conditions and future outlook with senior management.

Dimensional Fund Advisors Ltd. has disclosed a 1.27% interest in Prologis Inc., comprising 12,058,325 USD 0.01 common shares as of September 10, 2026. The disclosure was made under Rule 8.3 of the Takeover Code, with a purchase of 841 shares at $34.41 per unit and a transfer out of 324 shares also noted during the reporting period.

Rosen Law Firm is notifying investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) of a securities class action lawsuit with a September 22, 2026 lead plaintiff deadline. The lawsuit alleges that PROCEPT made materially false statements regarding its sales practices, including use of undisclosed discount programs that artificially inflated handpiece unit sales and revenues, created excess inventory of over 10,000 units, and made unachievable 2025 guidance. Investors with losses exceeding $100,000 are encouraged to seek counsel.

Kirby McInerney LLP is reminding PROCEPT BioRobotics investors of the September 22, 2026 deadline to seek lead plaintiff status in a federal securities class action. The lawsuit alleges the company made false statements about handpiece unit sales by concealing an extensive discount program that artificially inflated revenues and created over 10,000 excess units in field inventory. Stock declined significantly following earnings misses and guidance reductions in August, November 2025, and February 2026.

PROCEPT BioRobotics Corporation faces a class action securities fraud lawsuit alleging the company used an undisclosed discount program to artificially inflate handpiece sales and revenues between February 2024 and February 2026. The scheme allegedly created excess field inventory of over 10,000 units and misled investors about business performance, resulting in significant stock price declines following quarterly earnings revelations.